First Time Loading...

INVO Bioscience Inc
NASDAQ:INVO

Watchlist Manager
INVO Bioscience Inc Logo
INVO Bioscience Inc
NASDAQ:INVO
Watchlist
Price: 1.13 USD 2.73%
Updated: Mar 29, 2024

Intrinsic Value

INVO doesn't have a meaningful market cap.

INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. [ Read More ]

The intrinsic value of one INVO stock under the Base Case scenario is 29.23 USD. Compared to the current market price of 1.13 USD, INVO Bioscience Inc is Undervalued by 96%.

Key Points:
INVO Intrinsic Value
Base Case
29.23 USD
Undervaluation 96%
Intrinsic Value
Price
Base Case Scenario

Fundamental Analysis

How can I assist you today?

Provide an overview
of INVO Bioscience Inc's business.

What risks and challenges
does INVO Bioscience Inc face in the near future?

Summarize the latest earnings report
of INVO Bioscience Inc.

Provide P/E
for INVO Bioscience Inc and its competitors.

Financials

Balance Sheet Decomposition
INVO Bioscience Inc

Current Assets 1.8m
Cash & Short-Term Investments 1.1m
Receivables 120k
Other Current Assets 610k
Non-Current Assets 17.7m
Long-Term Investments 1.1m
PP&E 6.6m
Intangibles 10m
Other Non-Current Assets 10k
Current Liabilities 4.9m
Accounts Payable 1.9m
Accrued Liabilities 980k
Short-Term Debt 880k
Other Current Liabilities 1.2m
Non-Current Liabilities 14.2m
Long-Term Debt 1.1m
Other Non-Current Liabilities 13.1m
Efficiency

Earnings Waterfall
INVO Bioscience Inc

Revenue
1.9m USD
Cost of Revenue
-970k USD
Gross Profit
950k USD
Operating Expenses
-8.9m USD
Operating Income
-8m USD
Other Expenses
-820k USD
Net Income
-8.8m USD

Free Cash Flow Analysis
INVO Bioscience Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

INVO Profitability Score
Profitability Due Diligence

INVO Bioscience Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
ROIC is Increasing
Positive 3-Years Revenue Growth
27/100
Profitability
Score

INVO Bioscience Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

INVO Solvency Score
Solvency Due Diligence

INVO Bioscience Inc's solvency score is 17/100. The higher the solvency score, the more solvent the company is.

Positive Net Debt
Long-Term Solvency
Short-Term Solvency
High D/E
17/100
Solvency
Score

INVO Bioscience Inc's solvency score is 17/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INVO Price Targets Summary
INVO Bioscience Inc

There are no price targets for INVO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

INVO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

INVO Price
INVO Bioscience Inc

1M 1M
-2%
6M 6M
+43%
1Y 1Y
-91%
3Y 3Y
-99%
5Y 5Y
-100%
10Y 10Y
-96%
Annual Price Range
1.13
52w Low
0.54
52w High
12.78
Price Metrics
Average Annual Return -46.21%
Standard Deviation of Annual Returns 39.1%
Max Drawdown -100%
Shares Statistics
Market Capitalization 2.8m USD
Shares Outstanding 2 492 530
Percentage of Shares Shorted 0.45%

INVO Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

INVO Bioscience Inc Logo
INVO Bioscience Inc

Country

United States of America

Industry

Health Care

Market Cap

2.8m USD

Dividend Yield

0%

Description

INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. The company is headquartered in Lakewood Ranch, Florida and currently employs 10 full-time employees. The company went IPO on 2008-11-11. The firm is focused on expanding the assisted reproductive technology (ART) marketplace by making fertility care accessible and inclusive to people around the world. Its flagship product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. Its treatment solution is the intravaginal culture technique for the incubation of oocytes and sperm during fertilization and early embryo development. Its INVOcells inner chamber holds egg and sperm in a culture medium. Its INVO Centers offer the INVOcell and intravaginal culture (IVC) procedure, in addition to its selling of technology solutions into existing fertility clinics. The firm's subsidiaries include Bio X Cell, Inc., and Invo Centers, LLC.

Contact

FLORIDA
Lakewood Ranch
5582 Broadcast Ct
+19788789505.0
https://invobioscience.com/

IPO

2008-11-11

Employees

10

Officers

CEO & Director
Mr. Steven M. Shum
Chief Financial Officer
Mr. Andrea Goren
COO & VP of Business Development
Mr. Michael Jos. Campbell
Director of Sales US
Mr. Bojan Mitrovic Ph.D.
Treasurer & Secretary
Mr. Robert Joseph Bowdring Jr.
Controller
Ms. Terah Krigsvold

See Also

Discover More